230 related articles for article (PubMed ID: 15288306)
1. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG
Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
Nuermberger E; Bishai WR
Clin Infect Dis; 2004 Jan; 38(1):99-103. PubMed ID: 14679455
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
[TBL] [Abstract][Full Text] [Related]
4. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
5. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP;
Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J
Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
13. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
Jacobs MR
Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
[No Abstract] [Full Text] [Related]
14. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
[TBL] [Abstract][Full Text] [Related]
15. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
Farrell DJ; Couturier C; Hryniewicz W
Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
[TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia.
Kastrin T; Gubina M; Paragi M; Kolman J; Cizman M; Kraigher A; Ribic H; Sadowy E; Hryniewicz W
J Antimicrob Chemother; 2008 Sep; 62(3):628-9. PubMed ID: 18474511
[No Abstract] [Full Text] [Related]
17. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S
Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
Kelley MA; Weber DJ; Gilligan P; Cohen MS
Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
[TBL] [Abstract][Full Text] [Related]
19. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD; Low DE
Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
[TBL] [Abstract][Full Text] [Related]
20. Macrolide and ketolide resistance with Streptococcus pneumoniae.
Doern GV
Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
